Melinda M. Protani - Concepedia

Author

Melinda M. Protani

Also Known As

Joanna E. Fardell, Leah M Ferrucci, M Protani, M. Protani, M.M. Protani, Melinda M. Protani, Melinda M Protani, Melinda M. Protani, Melinda Protani

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland QIMR Berghofer Medical Research Institute The University of Sydney Westmead Institute Westmead Hospital

About

Melinda M. Protani is an author at The University of Queensland specializing in medicine, public health, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	410
2	Public Health	4	4	148
3	Epidemiology	2	2	63
4	Social Sciences	1	1	202
5	Child Development	1	1	202

Melinda M. Protani

Publications

602

Citations

H-Index

Page 1

	Year	Citations
Child maltreatment, subsequent non-suicidal self-injury and the mediating roles of dissociation, alexithymia and self-blame Sarah Swannell, Graham Martin, Andrew Page, Child Abuse & Neglect Mediating RolesMental HealthVictimisationTrauma In ChildPediatric Trauma	2012	202
Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis Yuanhai You, Mark R. Davies, Melinda M. Protani, EBioMedicine	2018	102
Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer Penelope M. Webb, Anna de Fazio, Melinda M. Protani, American Journal of Clinical Nutrition	2015	57
Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality Karen Tuesley, Melinda M. Protani, Penelope M. Webb, American Journal of Obstetrics and Gynecology LaparoscopyGynecologic SurgeryCause-specific MortalityGynecological SurgeryMinimally Invasive Procedure	2020	54
Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45–69 years in Queensland, Australia Louise F. Wilson, Andrew N. Page, Nathan Dunn, Maturitas Breast OncologyCancer RiskCancer EpidemiologyModifiable Risk FactorsInvasive Breast Cancer	2013	47
Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women James Carroll, Melinda M. Protani, Linda Nguyen, Medical Oncology Breast OncologyOncologyPharmacologyBreast CancerCancer Treatment	2014	35
Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival Suzanne C. Dixon‐Suen, Torukiri I Ibiebele, Melinda M. Protani, Gynecologic Oncology NutritionOvarian Cancer SurvivalMedicineDietary FolateGynecology	2013	31
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival Christina M. Nagle, Torukiri I Ibiebele, Anna DeFazio, Cancer Epidemiology Ovarian Cancer SurvivalOncologyAnti-inflammatoryMedicineGynecology	2015	25
Intersectional (in) equities in contact coverage of maternal and newborn health services in Nepal: insights from a nationwide cross-sectional household survey Resham B. Khatri, Yibeltal Alemu, Melinda M. Protani, BMC Public Health	2021	20
Breast cancer risk factors in Queensland women attending population-based mammography screening Melinda M. Protani, Andrew C. Page, Richard Taylor, Maturitas Cancer RiskCancer EpidemiologyCancer DetectionQueensland WomenCancer Screening	2012	16

Page 1